BioPharmaJournal.com has a strong base of loyal readers. To advertise with us please email us at [email protected]
Home Advertise
Advertise
Recent Post
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...
